News

AddToAny

Google+ Facebook Twitter Twitter

Cranberries to fight bacteria

Cranberries could play a role in the fight against bacteria, according to the results of new research.

p8-13-news-cranberries-istock-157503221-.jpg

When treated with molecules derived from cranberries, pathogenic bacteria become more sensitive to lower doses of antibiotics.

The researchers also state that the bacteria don’t develop resistance to the antibiotics.

They were looking into the issue due to the popular belief that drinking cranberry juice is helpful against urinary tract infections.

They sought to find out more about the berry’s molecular properties by treating various bacteria with a cranberry extract. 

The bacteria selected for study were those responsible for urinary tract infections, pneumonia, and gastro-enteritis (Proteus mirabilis, Pseudomonas aeruginosa, and Escherichia coli).

Nathalie Tufenkji, lead author of the study, said: “Normally when we treat bacteria with an antibiotic in the lab, the bacteria eventually acquire resistance over time. 

“But when we simultaneously treated the bacteria with an antibiotic and the cranberry extract, no resistance developed. 

“We were very surprised by this, and we see it as an important opportunity.”

Image credit | iStock

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top